Biomarkers and Clinical Features Guiding HER2-Directed Therapy in Upper GI Cancer

Opinion
Video

Experts discuss specific biomarkers or clinical features that would prompt earlier consideration of trastuzumab deruxtecan or other HER2-directed therapies.

Recent Videos
5 experts in this video
5 experts in this video
Related Content